NO20015398L - Endoparasitticidisk synergistisk kombinasjon inneholdende cykliske depsipeptider og piperaziner - Google Patents

Endoparasitticidisk synergistisk kombinasjon inneholdende cykliske depsipeptider og piperaziner

Info

Publication number
NO20015398L
NO20015398L NO20015398A NO20015398A NO20015398L NO 20015398 L NO20015398 L NO 20015398L NO 20015398 A NO20015398 A NO 20015398A NO 20015398 A NO20015398 A NO 20015398A NO 20015398 L NO20015398 L NO 20015398L
Authority
NO
Norway
Prior art keywords
endoparasiticidal
piperazines
depsipeptides
cyclic depsipeptides
containing cyclic
Prior art date
Application number
NO20015398A
Other languages
English (en)
Other versions
NO328870B1 (no
NO20015398D0 (no
Inventor
Achim Harder
Georg Samson-Himmelstjerna
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7907825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20015398(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20015398D0 publication Critical patent/NO20015398D0/no
Publication of NO20015398L publication Critical patent/NO20015398L/no
Publication of NO328870B1 publication Critical patent/NO328870B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO20015398A 1999-05-12 2001-11-05 Endoparasitticide midler inneholdende cykliske depsipeptider og piperaziner og anvendelse av piperaziner sammen med cykliske depsipeptider NO328870B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19921887A DE19921887A1 (de) 1999-05-12 1999-05-12 Endoparasitizide Mittel
PCT/EP2000/004014 WO2000069425A2 (de) 1999-05-12 2000-05-04 Endoparasitizide synergistische kombination enthaltend cyclischen depsipeptiden und piperazinen

Publications (3)

Publication Number Publication Date
NO20015398D0 NO20015398D0 (no) 2001-11-05
NO20015398L true NO20015398L (no) 2001-11-05
NO328870B1 NO328870B1 (no) 2010-06-07

Family

ID=7907825

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015398A NO328870B1 (no) 1999-05-12 2001-11-05 Endoparasitticide midler inneholdende cykliske depsipeptider og piperaziner og anvendelse av piperaziner sammen med cykliske depsipeptider

Country Status (26)

Country Link
EP (1) EP1189615B1 (no)
JP (1) JP2002544224A (no)
KR (1) KR100704717B1 (no)
CN (1) CN1224391C (no)
AT (1) ATE258795T1 (no)
AU (1) AU768910B2 (no)
BR (1) BR0010499A (no)
CA (1) CA2373827C (no)
CZ (1) CZ300782B6 (no)
DE (2) DE19921887A1 (no)
DK (1) DK1189615T3 (no)
ES (1) ES2211558T3 (no)
HK (1) HK1047228B (no)
HR (1) HRP20010918B1 (no)
HU (1) HUP0201201A3 (no)
MX (1) MXPA01011455A (no)
NO (1) NO328870B1 (no)
PL (1) PL200951B1 (no)
PT (1) PT1189615E (no)
RS (1) RS50169B (no)
RU (1) RU2250779C2 (no)
SK (1) SK285494B6 (no)
TR (2) TR200103240T2 (no)
UA (1) UA72520C2 (no)
WO (1) WO2000069425A2 (no)
ZA (1) ZA200108238B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
KR101671325B1 (ko) * 2015-01-09 2016-11-02 한국생명공학연구원 신규한 고리형 뎁시펩타이드계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 항균용 약학적 조성물
US10081656B2 (en) 2015-05-20 2018-09-25 Merial, Inc. Anthelmintic depsipeptide compounds
HUE065907T2 (hu) * 2015-12-28 2024-06-28 Boehringer Ingelheim Vetmedica Gmbh Anthelmintikus hatású depszipeptid vegyületek
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
CA3192377A1 (en) * 2020-09-11 2022-03-17 The Governing Council Of The University Of Toronto Piperazinyl compounds and methods for treating nematode infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA842571B (en) * 1983-04-07 1985-11-27 Merck & Co Inc Novel synergistic antiparasitic combinations
JPS6471865A (en) * 1987-09-11 1989-03-16 Nichibai Boeki Kk 1-alkylcarbamoyl-4-methylpiperazine derivative
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
US5646244A (en) * 1993-09-06 1997-07-08 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
JPH11513361A (ja) * 1995-09-07 1999-11-16 ファルマシア・アンド・アップジョン・カンパニー 環状駆虫性阻害剤
WO1998037088A1 (en) * 1997-02-19 1998-08-27 Meiji Seika Kaisha Ltd. Derivatives of cyclodepsipeptide, pf1022 substance
US6355615B1 (en) * 1997-06-04 2002-03-12 Bayer Aktiengesellschaft Desoxycyclodepsipeptides and their use for combatting endoparasites
WO2000008047A1 (en) * 1998-08-04 2000-02-17 Nisshin Flour Milling Co., Ltd. Depsipeptide derivatives bearing piperazinone rings

Also Published As

Publication number Publication date
HK1047228B (zh) 2006-07-21
CN1224391C (zh) 2005-10-26
ES2211558T3 (es) 2004-07-16
HRP20010918B1 (en) 2011-01-31
RS50169B (sr) 2009-05-06
SK285494B6 (sk) 2007-02-01
EP1189615A2 (de) 2002-03-27
RU2250779C2 (ru) 2005-04-27
KR20010109527A (ko) 2001-12-10
KR100704717B1 (ko) 2007-04-09
ZA200108238B (en) 2002-12-24
EP1189615B1 (de) 2004-02-04
AU768910B2 (en) 2004-01-08
CA2373827C (en) 2008-09-16
HUP0201201A2 (en) 2002-08-28
CZ20014060A3 (cs) 2002-06-12
HRP20010918A2 (en) 2003-04-30
ATE258795T1 (de) 2004-02-15
HK1047228A1 (en) 2003-02-14
PL200951B1 (pl) 2009-02-27
MXPA01011455A (es) 2002-07-30
CZ300782B6 (cs) 2009-08-12
UA72520C2 (uk) 2005-03-15
HUP0201201A3 (en) 2003-03-28
DE50005213D1 (de) 2004-03-11
CA2373827A1 (en) 2000-11-23
WO2000069425A3 (de) 2001-03-15
NO328870B1 (no) 2010-06-07
AU5523700A (en) 2000-12-05
TR200103240T2 (tr) 2002-04-22
TR200401875T2 (tr) 2005-01-24
PT1189615E (pt) 2004-05-31
CN1352559A (zh) 2002-06-05
JP2002544224A (ja) 2002-12-24
BR0010499A (pt) 2002-02-13
SK16262001A3 (sk) 2002-03-05
PL351376A1 (en) 2003-04-07
DK1189615T3 (da) 2004-06-07
DE19921887A1 (de) 2000-11-16
NO20015398D0 (no) 2001-11-05
YU80501A (sh) 2004-09-03
WO2000069425A2 (de) 2000-11-23

Similar Documents

Publication Publication Date Title
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
TR200103428T2 (tr) IMPDH enzim inhibitörleri.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
CY1113312T1 (el) Κυκλικοι αναστολεις κινασης τυροσινης πρωτεϊνων
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
DE60024414T2 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
BR0014381A (pt) Derivados de 5-beta-sapogenina e pseudossapogenina e seu uso no tratamento de demência
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
YU13301A (sh) Muskarinski agonisti i antagonisti
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
NO20015398D0 (no) Endoparasitticidisk synergistisk kombinasjon inneholdende cykliske depsipeptider og piperaziner
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
NO306292B1 (no) Triaryletylenderivater for anvendelse innen terapi
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
UA37545A (uk) Калієва сіль n-(1,4-діоксо-3-метил-1,4-дигідронафт-2-іл) гліцину, що проявляє антигіпоксичну та протиішемічну дію

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MM1K Lapsed by not paying the annual fees